연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1161. The effects of the stromal cell-derived cyclooxygenase-2 metabolite prostaglandin E2 on the proliferation of colon cancer cells.
Park SW, Kim HS, Choi MS, Jeong WJ, Heo DS, Kim KH, Sung MW.
J Pharmacol Exp Ther. 2011 Feb;336(2):516-23. Epub 2010 Nov 9.
Link
1160. The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines.
Park SW, Kim HS, Choi MS, Kim JE, Jeong WJ, Heo DS, Sung MW.
Anticancer Drugs. 2011 Jun;22(5):416-23.
Link
1159. The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells.
Park SW, Heo DS, Sung MW.
Cell Oncol (Dordr). 2012 Feb;35(1):1-8. Epub 2011 Jun 8.
Link
1158. Epigenetic-based therapies in cancer: progress to date.
Song SH, Han SW, Bang YJ.
Drugs. 2011 Dec 24;71(18):2391-403. doi: 10.2165/11596690-000000000-00000.
Link
1157. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer.
No JH, Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB, Han JY, Lim JM, Song YS.
Gynecol Oncol. 2011 Apr;121(1):8-12. Epub 2011 Jan 26.
Link
1156. Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas.
Lee CH, Roh JW, Choi JS, Kang S, Park IA, Chung HH, Jeon YT, Kim JW, Park NH, Kang SB, Song YS.
Int J Gynecol Cancer. 2011 May;21(4):668-72.
Link
1155. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer.
Kim MK, Kim K, Han JY, Lim JM, Song YS.
Genes Nutr. 2011 May;6(2):109-15. Epub 2011 Feb 4.
Link
1154. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH, Kim MK, Jeon YT, Kim YB, Song YS.
Mol Carcinog. 2011 Apr;50(4):244-53. doi: 10.1002/mc.20657.
Link
1153. Metabolic approaches to overcoming chemoresistance in ovarian cancer.
Suh DH, Kim MK, No JH, Chung HH, Song YS.
Ann N Y Acad Sci. 2011 Jul;1229:53-60. doi: 10.1111/j.1749-6632.2011.06095.x.
Link
1152. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.
Kim H, Kang HJ, Lee JW, Park KD, Shin HY, Ahn HS.
Ann Hematol. 2011 Nov 12. [Epub ahead of print]
Link